EMEA-003569-PIP01-23
Submitted by Anonymous (not verified) on 6 June 2025 - 14:20
EMEA-003569-PIP01-23
EMEA-003569-PIP01-23
EMEA-003405-PIP01-23
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 June 2025
PSUSA/00001842/202410
EMEA-003313-PIP03-23
EMEA-003540-PIP01-23
EMEA-003537-PIP01-23
EMEA-003528-PIP01-23
Opinion/decision on a Paediatric investigation plan (PIP): Piqray, Alpelisib, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Congenital, familial and genetic disorders, PIP number: P/0090/2024
Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) annual activity report 2024